Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

The Impacts of Genetic Polymorphisms on the Von Willebrand Factor Level in Type 1 Von Willebrand Disease

Yeu-Chin Chen, Chia-Yau Chang, Shin-Nan Cheng, Shiue-Wei Lai, Shu-Hsia Hu

Blood (2023) 142 (Supplement 1): 286.

https://doi.org/10.1182/blood-2023-180681

Published: 2023

Journal Articles

Baseline VWF:Ag Level and Body Mass Index Are Inverse Influencing Factors of Annualized Total Bleeding Rate and Annualized Joint Bleeding Rate Respectively in Severe-Type Adult Patients with Hemophilia a (PwHA) with Episodic Treatment with rFVIII

Chia-Yau Chang, Shiue-Wei Lai, Mei-Mei Cheng, Jung-Tzu Ku, Shu-Hsia Hu, Jia-Ruey Tsai, Chen-Hua Tsai, Pei-Yi Lai, Yen-Lin Liu, Chao-Neng Cheng, Yeu-Chin Chen

Blood (2021) 138 (Supplement 1): 3199.

https://doi.org/10.1182/blood-2021-150822

Published: 2021

Journal Articles

Real-World Bleeding Outcomes, Weekly Factor Consumption Doses, Annualized Factor Costs in Severe-Type Patients with Hemophilia a (PwHA) before and after Switching to Extended Half-Life rFVIII-Fc Prophylaxis

Chia-Yau Chang, Shiue-Wei Lai, Mei-Mei Cheng, Pei-Yi Lai, Jung-Tzu Ku, Shu-Hsia Hu, Chen-Hua Tsai, Chao-Neng Cheng, Yen-Lin Liu, Jia-Ruey Tsai, Yeu-Chin Chen

Blood (2021) 138 (Supplement 1): 3198.

https://doi.org/10.1182/blood-2021-152066

Published: 2021

Journal Articles

Clinical Predictors and Prediction Models for Frequency of Total and Joint Hemorrhage in Severe-Type Patients with Hemophilia a (PwHA) with/without Intermediate-Dose Prophylaxis Therapy with rFVIII

Chia-Yau Chang, Shiue-Wei Lai, Mei-Mei Cheng, Jung-Tzu Ku, Shu-Hsia Hu, Chen-Hua Tsai, Pei-Yi Lai, Yen-Lin Liu, Jia-Ruey Tsai, Chao-Neng Cheng, Yeu-Chin Chen

Blood (2021) 138 (Supplement 1): 1047.

https://doi.org/10.1182/blood-2021-147069

Published: 2021